EP2470270 - COMPOUNDS FOR TREATMENT OF INFLAMMATION [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 13.01.2017 Database last updated on 16.07.2024 | Most recent event Tooltip | 13.01.2017 | Application deemed to be withdrawn | published on 15.02.2017 [2017/07] | Applicant(s) | For all designated states HPF IP Holding S.A. 231 Val de Bons Malades 2121 Luxembourg-Kirchberg / LU | [2016/21] |
Former [2012/27] | For all designated states AnaMar AB Kungsportsavenyn 22 411 36 Goteborg / SE | Inventor(s) | 01 /
PALMQVIST, Niklas Friisgatan 11A S-214 21 Malmö / SE | 02 /
SJÖDIN, Anders Klaragatan 25 S-240 30 Marieholm / SE | 03 /
WENGLÉN, Christina Hagavägen 2A S-237 35 Bjärred / SE | 04 /
FLOOD, Christofer Norra Rydbergsvägen 2 S-443 50 Lerum / SE | 05 /
LUNDBERG, Lennart Resliden 16 S-427 36 Billdal / SE | 06 /
SEIFERT, Elisabeth Rotyxvägen 17 S-756 48 Uppsala / SE | 07 /
LEK, Per Bernardottevägen 9 S-756 48 Uppsala / SE | 08 /
BOMAN, Arne Tjudervägen 6 S-756 47 Uppsala / SE | [2012/27] | Representative(s) | Valea AB Box 17067 200 10 Malmö / SE | [N/P] |
Former [2012/27] | Webber, Philip Michael Dehns St Bride's House 10 Salisbury Square London EC4Y 8JD / GB | Application number, filing date | 10739974.3 | 30.07.2010 | WO2010GB01457 | Priority number, date | GB20090013427 | 31.07.2009 Original published format: GB 0913427 | GB20100005495 | 31.03.2010 Original published format: GB 201005495 | GB20100010671 | 24.06.2010 Original published format: GB 201010671 | [2012/27] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2011012868 | Date: | 03.02.2011 | Language: | EN | [2011/05] | Type: | A1 Application with search report | No.: | EP2470270 | Date: | 04.07.2012 | Language: | EN | The application published by WIPO in one of the EPO official languages on 03.02.2011 takes the place of the publication of the European patent application. | [2012/27] | Search report(s) | International search report - published on: | EP | 03.02.2011 | Classification | IPC: | A61P29/00, A61K31/155, A61K31/36, A61K31/385 | [2012/27] | CPC: |
A61K31/385 (EP,US);
A61K31/155 (EP,GB,US);
A61K31/36 (EP,US);
A61K31/444 (GB);
A61K31/506 (GB);
A61P19/02 (EP);
A61P25/00 (EP);
A61P25/04 (EP);
A61P29/00 (EP);
A61P43/00 (EP)
(-)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, SM, TR [2012/27] | Title | German: | VERBINDUNGEN ZUR BEHANDLUNG VON ENTZÜNDUNGEN | [2012/27] | English: | COMPOUNDS FOR TREATMENT OF INFLAMMATION | [2012/27] | French: | COMPOSÉS POUR LE TRAITEMENT DE L'INFLAMMATION | [2012/27] | Entry into regional phase | 21.02.2012 | National basic fee paid | 21.02.2012 | Designation fee(s) paid | 21.02.2012 | Examination fee paid | Examination procedure | 21.02.2012 | Amendment by applicant (claims and/or description) | 21.02.2012 | Examination requested [2012/27] | 21.02.2014 | Despatch of a communication from the examining division (Time limit: M06) | 05.12.2014 | Reply to a communication from the examining division | 29.04.2016 | Despatch of a communication from the examining division (Time limit: M04) | 10.09.2016 | Application deemed to be withdrawn, date of legal effect [2017/07] | 10.10.2016 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2017/07] | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 21.02.2014 | Request for further processing for: | The application is deemed to be withdrawn due to failure to reply to the examination report | 05.12.2014 | Request for further processing filed | 05.12.2014 | Full payment received (date of receipt of payment) Request granted | 15.12.2014 | Decision despatched | Fees paid | Renewal fee | 27.07.2012 | Renewal fee patent year 03 | 26.07.2013 | Renewal fee patent year 04 | 23.07.2014 | Renewal fee patent year 05 | 21.07.2015 | Renewal fee patent year 06 | Penalty fee | Additional fee for renewal fee | 31.07.2013 | 04   M06   Not yet paid | 31.07.2016 | 07   M06   Not yet paid |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [X]WO9113622 (BETH ISRAEL HOSPITAL [US]); | [X]EP0711553 (CAGNONI MARIO [IT]); | [X]US5905083 (CINCOTTA ANTHONY H [US], et al); | [X]WO0125192 (MELACURE THERAPEUTICS AB [SE], et al); | [X]WO0211715 (MELACURE THERAPEUTICS AB [SE], et al); | [A]US2003166672 (LUBBERT HERMANN [DE], et al); | [X]WO2008061647 (ACURE PHARMA AB [SE], et al); | [XI]WO2008090334 (IMP INNOVATIONS LTD [GB], et al); | [A]WO2009016225 (GLAXO GROUP LTD [GB], et al); | [E]WO2010109192 (ANAMAR AB [SE], et al) | by applicant | WO0211715 |